Abstract
Genetic research has moved from Mendelian genetics to sequence maps to the study of natural human genetic variation at the level of the genome. This past decade of discovery has been accompanied by a shift in emphasis towards the ethical principles of reciprocity, mutuality, solidarity, citizenry and universality.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
What does engagement mean to participants in longitudinal cohort studies? A qualitative study
BMC Medical Ethics Open Access 24 June 2021
-
Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health
Science and Engineering Ethics Open Access 21 April 2021
-
Human genome editing: how to prevent rogue actors
BMC Medical Ethics Open Access 06 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Knoppers, B. M. & Chadwick, R. The Human Genome Project: under an international ethical microscope. Science 265, 2035–2036 (1994).
World Health Organization. Genetic databases: assessing the benefits and the impact on human and patient rights (World Health Organization, Geneva, 2003).
Marteau, T. & Richards, M. (eds) The Troubled Helix: Social and Psychological Implications of the New Genetics (Cambridge Univ. Press, Cambridge, 1996).
Clarke, A. (ed.) Genetic Counselling: Practice and Principles (Routledge, London, 1994).
Wertz, D. C. Ethical and legal implications of the new genetics: issues for discussion. Soc. Sci. Med. 35, 495–505 (1992).
Danish Council on Ethics. Ethics and mapping of the human genome (Danish Council on Ethics, Copenhagen, 1993).
Nuffield Council on Bioethics. Genetic screening: ethical issues (Nuffield Council on Bioethics, London, 1993).
NIH-DOE Working Group on Ethical, Legal and Social Implications of Human Genome Research. Genetic information and health insurance report of the task force on genetic information and insurance (US National Institutes of Health, Bethesda, 1993).
Committee on the Ethics of Gene Therapy. Report of the committee on the ethics of gene therapy (UK Department of Health, London, 1992).
De Wachter, M. A. M. Ethical aspects of human germ-line gene therapy. Bioethics 7, 166–177 (1993).
Pembrey, M. in Ethics in Reproductive Medicine (eds Bromham, D. et al.) 11–20 (Springer, London, 1992).
National Bioethics Advisory Commission. Cloning human beings (National Bioethics Advisory Council, Rockville, 1997).
Robertson, J. Liberty, identity, and human cloning. Tex. Law Rev. 76, 1371–1456 (1998).
Knoppers, B. M., Hirtle M. & Glass K. C. Commercialization of genetic research and public policy. Science 286, 2277–2278 (1999).
Burgess, M. in The Commercialisation of Genetic Research: Legal Ethical and Policy Issues (eds Caulfield, T. & Williams-Jones, B.) 181–194 (Kluwer Academic Plenum, New York, 1999).
Resnik, D. B. The morality of human gene patents. Kennedy Inst. Ethics J. 7, 43–61 (1997).
Estonian Government. Human genes research act (RT I 2000, 104, 685) <http://cmgm.stanford.edu/biochem118/Papers/Genome%20Papers/Estonian%20Genome%20Res%20Act.pdf> (2001).
123rd Parliament, Iceland. Act on a health sector database no. 139/1998 (1998).
Buchanan, A. et al. Pharmacogenetics — ethical and regulatory issues in research and clinical practice: report of the consortium on pharmacogenetics, findings and recommendations (Consortium on Pharmacogenetics, Minneapolis, 2002).
Nuffield Council on Bioethics. Pharmacogenetics: ethical issues <http://www.nuffieldbioethics.org/fileLibrary/pdf/pharm_short_version2.pdf> (Nuffield Council on Bioethics, London, 2003).
Nuffield Council on Bioethics. The use of genetically modified crops in developing countries <http://www.nuffieldbioethics.org/fileLibrary/pdf/ GM_Crops_short_version_FINAL.pdf> (Nuffield Council on Bioethics, London, 2004).
Bell, J. The new genetics in clinical practice. BMJ 316, 618–620 (1998).
Roses, A. D. Pharmacogenetics and future drug development and delivery. Lancet 355, 1358–1361 (2000).
Roses, A. D. Pharmacogenetics and the practice of medicine. Nature 15, 857–865 (2000).
Kegley, J. A. in Genetic Information: Acquisition, Access and Control (eds Thompson, A. & Chadwick, R.) 321–329 (Kluwer Academic, New York, 1997).
Beyleveld, D. & Brownsword, R. Human Dignity in Bioethics and Biolaw (Oxford Univ. Press, Oxford, 2001).
Gallagher, A. in Genetic Information: Acquisition, Access and Control (eds Thompson, A. & Chadwick, R.) 267–273 (Kluwer Academic, New York, 1997).
Baylis, F., Downie, J. & Sherwin, S. in Embodying Bioethics: Recent Feminist Advances (eds Donchin, A. & Purdy, L.) 253–268 (Rowman & Littlefield, New York, 1999).
Network of Applied Genetic Medicine. Statement of principles: human genomic research (<http://www.rmga.qc.ca/en/index.htm>/Network of Applied Genetic Medicine, Montreal, 2000).
Deschênes, M., Cardinal, G., Knoppers, B. M. & Glass, K. C. Human genetic research, DNA banking and consent: a question of 'form'? Clin. Genet. 59, 221–239 (2001).
UNESCO International Bioethics Committee. International declaration on human genetic data (UNESCO, Paris, 2003).
Beskow, L. et al. Informed consent for population-based research involving genetics. JAMA 286, 2315–2321 (2001).
HUGO Ethics Committee. Statement on DNA sampling: control and access <http://www.mext.go.jp/a_menu/shinkou/seimei/genomeshishin/html/ guideline/hugo-e.pdf> (Human Genome Organisation, London, 1998).
Godard, B., ten Kate, L., Evers-Kiebooms, G. & Aymé, S. Population genetic screening programmes: principles, techniques and policies. Eur. J. Hum. Genet. 11 (Suppl. 2), 49–87 (2003).
DeCode Genetics. Code of ethics (DeCode Genetics, Reykjavik, 2000).
HUGO Ethics Committee. Statement on the principled conduct of genetic research (Human Genome Organisation, London, 1996).
Quebec Network of Applied Genetic Medicine. Statement of principles on the ethical conduct of human genetic research involving populations (Quebec, 2003).
CARTaGENE. CARTaGENE project [online] <http://www.cartagene.qc.ca/en/index.htm> (2003).
Knoppers, B. M. (ed.) Populations and Genetics: Legal and Socio-Ethical Perspectives (Martinus Nijhoff, Leiden, 2003).
Knoppers, B. Biobanks: simplifying consent. Nature Rev. Genet. 5, 485 (2004).
President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioural Research. Screening and counselling for genetic conditions: a report on the ethical, social, and legal implications of genetic screening, counselling, and education programs (US Government Printing Office, Washington DC, 1982).
Clayton, E. W. Ethical, legal, and social implications of genomic medicine. N. Engl. J. Med. 349, 562–569 (2003).
The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Professional disclosure of familial genetic information. Am. J. Hum. Genet. 62, 474–483 (1998).
World Health Organization. Proposed international guidelines on ethical issues in medical genetics and genetic services (World Health Organization, Geneva, 1998).
McGleenan, T. E. & Wiesing, U. Insurance and genetics: european policy options. Eur. J. Health Law 7, 367–383 (2000).
Chadwick, R. Genetics, choice and responsibility. Health, Risk Soc. 1, 293–300 (1999).
Buchanan, A. et al. From Chance to Choice (Cambridge Univ. Press, Cambridge, 2000).
Chadwick, R., Levitt, M. A. & Shickle D. (eds) The Right to Know and the Right Not to Know (Aldershot, Ashgate, 1997).
Rhodes, R. Genetic links, family ties, and social bonds: rights and responsibilities in the face of genetic knowledge. J. Med. Philos. 23, 10–30 (1998).
Berg, K. in Proceedings of the 2nd Symposium of the Council of Europe on Bioethics 122–143 (Council of Europe Press, Strasbourg, 1994).
Chadwick, R. et al. Euroscreen 2: Towards Community Policy on Insurance, Commercialization and Public Awareness. J. Med. Philos. 26, 263–272 (2001).
McGleenan, T., Wiesing, U. & Ewald, F. (eds) Genetics and Insurance (BIOS Scientific, Oxford, 1999).
Chadwick, R. & Berg, K. Solidarity and equity: new ethical frameworks for genetic databases. Nature Rev. Genet. 2, 318–321 (2001).
HUGO Ethics Committee. Statement on human genomic databases <http://www.gene.ucl.ac.uk/hugo/HEC_Dec02.html> (Human Genome Organisation, London, 2003).
Titmus, R. M. The Gift Relationship: from Human Blood to Social Policy (Allen & Unwin, London, 1970).
Medical Research Council. Report of the Medical Research Council Working Group to develop operational and ethical guidelines, human tissue and biological samples for use in research (Medical Research Council, London, 1999).
Annas, G. J. Rules for research on human genetic variation — lessons from Iceland. N. Engl. J. Med. 342, 1830–1833 (2000).
Medical Research Council. Human tissue and biological samples for use in research: operational and ethical guidelines (Medical Research Council, London, 2001).
National Bioethics Advisory Commission. Research involving human biological materials: ethical issues and policy guidance (National Bioethics Advisory Commission, Springfield, 1999).
Turney, J. Public understanding of science. Lancet 347, 1087–1090 (1996).
Kerr, A., Cunningham-Burley, S. & Amos, A. The new genetics and health: mobilising lay expertise. Public Underst. Sci. 7, 41–60 (1999).
Grove-White, R., Macnaghten, P., Mayer, S. & Wynne, B. Uncertain World: Genetically Modified Organisms, Food and Public Attitudes in Britain (IEPPP, Lancaster Univ., Lancaster, 1997).
Levitt, M. The Gene Shop: Evaluation of a Public Education Facility (Univ. Central Lancashire, Preston, 1998).
Lenaghan, J. Setting priorities: is there a role for citizen's juries? Br. J. Health Care Manage. 312, 1591–1593 (1996).
European Commission. The Europeans and modern biotechnology. Eurobarometer 46 <http://sherlock.mcgill.ca/ENQ–10303/doc/cb6940.pdf> (1997).
Chadwick, R. The Icelandic database — do modern times need modern sagas? BMJ 319, 441–444 (1999).
Sveinbjornsdottir, S. et al. Familial aggregation of Parkinson's disease in Iceland. N. Engl. J. Med. 343, 1765–1770 (2000).
Knoppers, B. M. Of populations, genetics and banks. Genetics Law Monitor Jan/Feb, 3–6 (2001).
Merz, J. F., McGee, G. E. & Sankar, P. “Iceland Inc.”?: on the ethics of commercial population genomics. Soc. Sci. Med. 58, 1201–1209 (2004).
Austin, M. A., Harding, S. & McElroy, C. Genebanks: a comparison of eight proposed international genetic databases. Community Genet. 6, 37–45 (2003).
Medical Research Council. BioBank UK consultation workshop (Medical Research Council, London, 2002).
Haimes, E. What can the social sciences contribute to the study of ethics? Theoretical, empirical and substantive considerations. Bioethics 16, 89–113 (2002).
Weiss, K. M. et al. Proposed model ethical protocol for collecting DNA samples. Houst. Law Rev. 33, 1431–1474 (1997).
International HapMap Project. About the International HapMap Project [online] <http://www.hapmap.org/abouthapmap.html.en> (2004).
Parens, E. & Asch, A. The disability rights critique of prenatal genetic testing: reflections and recommendations. Hastings Center Rep. 29, S1–S22 (1999).
Shakespeare, T. 'Losing the plot'? Medical and activist discourses of contemporary genetics and disability. Sociol. Health Illn. 21, 669–688 (2000).
Shakespeare, T. Arguing about disability and genetics. Interaction 13, 11–14 (2000).
Hull, R. Defining disability — a philosophical approach. Res. Publica. 4, 199–210 (1998)
UNESCO International Bioethics Committee. Universal declaration on the human genome and human rights (UNESCO, Paris, 1997).
Knoppers, B. M. in The Commercialization of Genetic Research: Ethical, Legal and Policy Issues (eds Caulfield, T. & Williams-Jones, B.) 1–11 (Kluwer Academic Plenum, New York, 1999).
HUGO Ethics Committee. Statement on benefit sharing (Human Genome Organisation, London, 2000).
Kaul, I., Grunberg, I. & Stern, M. Global Public Goods: International Cooperation in the 21st Century (Oxford Univ. Press, New York, 1999).
UNESCO. Report by the Director-General on the work of the International Bioethics Committee (IBC) and the Intergovernmental Bioethics Committee (IGBC) (UNESCO, Paris, 2003).
UNESCO. Report by the Director-General on the possibility of elaborating universal norms on bioethics (UNESCO, Paris, 2003).
Editorial. Defining a new bioethic. Nature Genet. 28, 297–298 (2001).
Husted, J. in The Right to Know and the Right Not to Know (eds Chadwick, R., Levitt, M. A. & Shickle, D.) 55–69 (Avebury Press, Aldershot, UK 1997).
Tucker, B. P. Deaf culture, cochlear implants, and elective disability. Hastings Center Rep. 28, 6–9 (1998).
Lippman, A. Genetic testing and screening: constructing needs and reinforcing inequities. Amer. J. Law Med. 17, 15–50 (1991).
McGleenan, T. in The Right to Know and the Right Not to Know (eds Chadwick, R., Levitt, M. A. & Shickle, D.) 43–54 (Avebury, Aldershot, UK, 1997).
Acknowledgements
The authors would like to acknowledge the invaluable assistance of Yann Joly of the Genetics and Society Project, CRDP, University of Montreal (http://www.humgen.umontreal.ca).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Knoppers, B., Chadwick, R. Human genetic research: emerging trends in ethics. Nat Rev Genet 6, 75–79 (2005). https://doi.org/10.1038/nrg1505
Issue Date:
DOI: https://doi.org/10.1038/nrg1505
This article is cited by
-
What does engagement mean to participants in longitudinal cohort studies? A qualitative study
BMC Medical Ethics (2021)
-
Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health
Science and Engineering Ethics (2021)
-
Public awareness of and attitudes towards research biobanks in Latvia
BMC Medical Ethics (2020)
-
Human genome editing: how to prevent rogue actors
BMC Medical Ethics (2020)